These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 19755201

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL, Lamb RA.
    Virology; 1997 Sep 29; 236(2):234-48. PubMed ID: 9325231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.
    Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA.
    EMBO J; 2001 Aug 15; 20(16):4432-42. PubMed ID: 11500371
    [Abstract] [Full Text] [Related]

  • 9. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T, Epand RF, Epand RM, Blumenthal R.
    Virology; 2001 Oct 25; 289(2):353-61. PubMed ID: 11689057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA.
    Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235
    [Abstract] [Full Text] [Related]

  • 14. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.
    Paterson RG, Russell CJ, Lamb RA.
    Virology; 2000 Apr 25; 270(1):17-30. PubMed ID: 10772976
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics.
    Su Y, Zhu X, Wang Y, Wu M, Tien P.
    Arch Virol; 2008 Apr 25; 153(2):247-57. PubMed ID: 18030546
    [Abstract] [Full Text] [Related]

  • 16. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2.
    Keleta L, Ibricevic A, Bovin NV, Brody SL, Brown EG.
    J Virol; 2008 Dec 25; 82(23):11599-608. PubMed ID: 18829764
    [Abstract] [Full Text] [Related]

  • 17. Composition and functions of the influenza fusion peptide.
    Cross KJ, Langley WA, Russell RJ, Skehel JJ, Steinhauer DA.
    Protein Pept Lett; 2009 Dec 25; 16(7):766-78. PubMed ID: 19601906
    [Abstract] [Full Text] [Related]

  • 18. Full-length influenza hemagglutinin HA2 refolds into the trimeric low-pH-induced conformation.
    Swalley SE, Baker BM, Calder LJ, Harrison SC, Skehel JJ, Wiley DC.
    Biochemistry; 2004 May 18; 43(19):5902-11. PubMed ID: 15134464
    [Abstract] [Full Text] [Related]

  • 19. [Active site for fusion activity of influenza virus hemagglutinin].
    Ohuchi M, Ohuchi R.
    Nihon Rinsho; 1997 Oct 18; 55(10):2648-53. PubMed ID: 9360385
    [Abstract] [Full Text] [Related]

  • 20. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
    Matsubara T, Onishi A, Saito T, Shimada A, Inoue H, Taki T, Nagata K, Okahata Y, Sato T.
    J Med Chem; 2010 Jun 10; 53(11):4441-9. PubMed ID: 20476787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.